Search
for
Sort by
Research 421–450 of 1000+
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- 5-Alpha reductase deficiency
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Hormonal manipulation of benign prostatic hyperplasia
- Therapeutic Androgen Receptor Ligands
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Finasteride-related Leydig cell tumour: report of a case and literature review
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Dermatological aspects of gender affirming medical treatment in transgender and gender diverse people: A systematic review
- Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS
- Prescribing to save patients money: Ethical considerations
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Introduction to: Endocrinological aspects of andrology—what is new?
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Docosahexaenoic acid-acylated astaxanthin esters alleviate cisplatin- induced acute kidney injury by modulating the ferroptosis-related GPX4/xCT signaling pathway and reducing oxidative stress
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital